Stock Events

Seegene 

₩23,550
2
+₩50+0.21% Today

Statistics

Day High
24,650
Day Low
23,300
52W High
35,950
52W Low
19,060
Volume
368,855
Avg. Volume
1,518,792
Mkt Cap
1.11T
P/E Ratio
-
Dividend Yield
3.4%
Dividend
801.7

Upcoming

13
NOV
Earnings
 
27
DEC
Dividend Ex
Estimated
 
28
MAR 25
Dividend Ex
Estimated
 
19
APR 25
Dividend Payment
Estimated
 
28
MAY 25
Dividend Payment
Estimated
 
27
JUN 25
Dividend Ex
Estimated
 
27
AUG 25
Dividend Payment
Estimated
 
26
SEP 25
Dividend Ex
Estimated
 
28
NOV 25
Dividend Payment
Estimated
 
27
DEC 25
Dividend Ex
Estimated
 

Dividends

3.4%Dividend Yield
Aug 24
₩200
May 24
₩200
Apr 24
₩200
Nov 23
₩200
Aug 23
₩200
10Y Growth
N/A
5Y Growth
64.38%
3Y Growth
-15.66%
1Y Growth
-25%

Earnings

13NovExpected
Q1 2023
Q2 2023
Q3 2023
Q4 2023
Q1 2024
Q2 2024
Next
999
333
-333
-999
Expected EPS
N/A
Actual EPS
N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow 096530.KQ. It's not an investment recommendation.
Alphabet
78395
GOOGL
Apple
68177
AAPL
Microsoft
63621
MSFT
Amazon
59331
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Qiagen NV
QGEN
Mkt Cap10.16B
QIAGEN N.V. offers molecular diagnostics technologies, similar to Seegene's diagnostic solutions, making them direct competitors in the healthcare diagnostics market.
Hologic
HOLX
Mkt Cap18.87B
Hologic, Inc. specializes in diagnostics and medical imaging systems, including molecular diagnostic products that compete with Seegene's offerings.
Bio-Rad Laboratories
BIO
Mkt Cap9.35B
Thermo Fisher Scientific
TMO
Mkt Cap234.95B
Thermo Fisher Scientific Inc. offers similar diagnostic and research products, competing in the same space as Seegene with a broad portfolio in diagnostics.
Quest Diagnostics
DGX
Mkt Cap17.47B
Quest Diagnostics Incorporated is a provider of diagnostic information services, which includes molecular diagnostics, competing with Seegene's diagnostic solutions.
Agilent Technologies
A
Mkt Cap41.06B
Agilent Technologies, Inc. provides instruments, services, and consumables for laboratories, including those in the diagnostics field, making it a competitor to Seegene.
PERKINELMER INC
PKI
Mkt Cap16.9B
PerkinElmer Inc. provides diagnostic products and services, including genetic testing and molecular screening, areas where Seegene also operates.
Roche
RHHBY
Mkt Cap272.83B
Roche Holding AG offers diagnostic systems and tests, including molecular diagnostics, directly competing with Seegene in the healthcare diagnostics market.
Danaher
DHR
Mkt Cap194.5B
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services, including diagnostics, competing with Seegene.
Illumina
ILMN
Mkt Cap20.93B

About

Seegene, Inc. manufactures and sells molecular diagnostics products worldwide. It offers IVD products comprising respiratory disease detection products for respiratory infections; gastrointestinal disease detection products for gastrointestinal tract infections; human papillomavirus detection products; sexually transmitted infections causative pathogens detection products; tuberculosis detection products; drug resistance products; Magicplex sepsis real-time test for the detection and identification of sepsis causing pathogens; and meningitis detection products. The company also provides other products for the detection of SNPs in factor II, factor V, and MTHFR genes. The company has a collaboration with Werfen for the joint development of syndromic qPCR assays. Seegene, Inc. was founded in 2000 and is headquartered in Seoul, South Korea.
Show more...
CEO
Dr. Jong-Yoon Chun
Country
KR
ISIN
KR7096530001

Listings

KQ
KR
096530.KQ